▶ 調査レポート

サクビトリルAPIのグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Sacubitril API Market Insights, Forecast to 2028

QYResearchが調査・発行した産業分析レポートです。サクビトリルAPIのグローバル市場インサイト・予測(~2028年) / Global Sacubitril API Market Insights, Forecast to 2028 / MRC2Q12-03158資料のイメージです。• レポートコード:MRC2Q12-03158
• 出版社/出版日:QYResearch / 2022年12月
• レポート形態:英文、PDF、114ページ
• 納品方法:Eメール(納期:3営業日)
• 産業分類:化学&材料
• 販売価格(消費税別)
  Single User¥725,200 (USD4,900)▷ お問い合わせ
  Enterprise License¥1,450,400 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
コロナ禍により、サクビトリルAPIの世界市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にサクビトリルAPIのグローバル市場のxxx%を占める「98%以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「錠剤」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
サクビトリルAPIの中国市場規模は2021年にUS$xxxと分析されており、アメリカとヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。アメリカの割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパのサクビトリルAPI市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

サクビトリルAPIのグローバル主要プレイヤーには、Mylan、NEWEDGE Overseas、Summit Pharmaceuticals Europe Srl、Zhejiang Tianyu Pharmaceutical、Unichem Laboratories Limited、Laurus Labs、Biocon、Viwit Pharmaceuticals Limited、Aurobindo Pharma Limited、Lee Pharma、Bulat Pharmaceutical、Chunghwa Chemical Synthesis & Biotech Co. Ltd.、IOL Chemicals And Pharmaceuticals Limitedなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

サクビトリルAPI市場は、種類と用途によって区分されます。世界のサクビトリルAPI市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
98%以上、99%以上

【用途別セグメント】
錠剤、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- サクビトリルAPI製品概要
- 種類別市場(98%以上、99%以上)
- 用途別市場(錠剤、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界のサクビトリルAPI販売量予測2017-2028
- 世界のサクビトリルAPI売上予測2017-2028
- サクビトリルAPIの地域別販売量
- サクビトリルAPIの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別サクビトリルAPI販売量
- 主要メーカー別サクビトリルAPI売上
- 主要メーカー別サクビトリルAPI価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(98%以上、99%以上)
- サクビトリルAPIの種類別販売量
- サクビトリルAPIの種類別売上
- サクビトリルAPIの種類別価格
・用途別市場規模(錠剤、その他)
- サクビトリルAPIの用途別販売量
- サクビトリルAPIの用途別売上
- サクビトリルAPIの用途別価格
・北米市場
- 北米のサクビトリルAPI市場規模(種類別、用途別)
- 主要国別のサクビトリルAPI市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパのサクビトリルAPI市場規模(種類別、用途別)
- 主要国別のサクビトリルAPI市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋のサクビトリルAPI市場規模(種類別、用途別)
- 主要国別のサクビトリルAPI市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米のサクビトリルAPI市場規模(種類別、用途別)
- 主要国別のサクビトリルAPI市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカのサクビトリルAPI市場規模(種類別、用途別)
- 主要国別のサクビトリルAPI市場規模(トルコ、サウジアラビア)
・企業情報
Mylan、NEWEDGE Overseas、Summit Pharmaceuticals Europe Srl、Zhejiang Tianyu Pharmaceutical、Unichem Laboratories Limited、Laurus Labs、Biocon、Viwit Pharmaceuticals Limited、Aurobindo Pharma Limited、Lee Pharma、Bulat Pharmaceutical、Chunghwa Chemical Synthesis & Biotech Co. Ltd.、IOL Chemicals And Pharmaceuticals Limited
・産業チェーン及び販売チャネル分析
- サクビトリルAPIの産業チェーン分析
- サクビトリルAPIの原材料
- サクビトリルAPIの生産プロセス
- サクビトリルAPIの販売及びマーケティング
- サクビトリルAPIの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- サクビトリルAPIの産業動向
- サクビトリルAPIのマーケットドライバー
- サクビトリルAPIの課題
- サクビトリルAPIの阻害要因
・主な調査結果

Sacubitril(CAS:1038924-61-6) is an antihypertensive drug used in combination with valsartan.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Sacubitril API estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Sacubitril API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Sacubitril API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Sacubitril API is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Sacubitril API include Mylan, NEWEDGE Overseas, Summit Pharmaceuticals Europe Srl, Zhejiang Tianyu Pharmaceutical, Unichem Laboratories Limited, Laurus Labs, Biocon, Viwit Pharmaceuticals Limited and Aurobindo Pharma Limited, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Sacubitril API production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Sacubitril API by region (region level and country level), by company, by Purity and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Sacubitril API manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Sacubitril API market. Further, it explains the major drivers and regional dynamics of the global Sacubitril API market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Mylan
NEWEDGE Overseas
Summit Pharmaceuticals Europe Srl
Zhejiang Tianyu Pharmaceutical
Unichem Laboratories Limited
Laurus Labs
Biocon
Viwit Pharmaceuticals Limited
Aurobindo Pharma Limited
Lee Pharma
Bulat Pharmaceutical
Chunghwa Chemical Synthesis & Biotech Co. Ltd.
IOL Chemicals And Pharmaceuticals Limited
Market Segments
This report has explored the key segments: by Purity and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Sacubitril API Segment by Purity
Above 98 %
Above 99 %
Sacubitril API Segment by Application
Tablets
Others
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Sacubitril API production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Sacubitril API market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Sacubitril API, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Sacubitril API, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Sacubitril API, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Sacubitril API sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Sacubitril API market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Sacubitril API sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Mylan, NEWEDGE Overseas, Summit Pharmaceuticals Europe Srl, Zhejiang Tianyu Pharmaceutical, Unichem Laboratories Limited, Laurus Labs, Biocon, Viwit Pharmaceuticals Limited and Aurobindo Pharma Limited, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sacubitril API capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Sacubitril API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Sacubitril API manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by purity, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by purity, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by purity, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by purity, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by purity, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sacubitril API sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.

レポート目次

1 Study Coverage
1.1 Sacubitril API Product Introduction
1.2 Market by Purity
1.2.1 Global Sacubitril API Market Size by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 98 %
1.2.3 Above 99 %
1.3 Market by Application
1.3.1 Global Sacubitril API Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Tablets
1.3.3 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Sacubitril API Production
2.1 Global Sacubitril API Production Capacity (2017-2028)
2.2 Global Sacubitril API Production by Region: 2017 VS 2021 VS 2028
2.3 Global Sacubitril API Production by Region
2.3.1 Global Sacubitril API Historic Production by Region (2017-2022)
2.3.2 Global Sacubitril API Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 India
3 Global Sacubitril API Sales in Volume & Value Estimates and Forecasts
3.1 Global Sacubitril API Sales Estimates and Forecasts 2017-2028
3.2 Global Sacubitril API Revenue Estimates and Forecasts 2017-2028
3.3 Global Sacubitril API Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Sacubitril API Sales by Region
3.4.1 Global Sacubitril API Sales by Region (2017-2022)
3.4.2 Global Sales Sacubitril API by Region (2023-2028)
3.5 Global Sacubitril API Revenue by Region
3.5.1 Global Sacubitril API Revenue by Region (2017-2022)
3.5.2 Global Sacubitril API Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Sacubitril API Production Capacity by Manufacturers
4.2 Global Sacubitril API Sales by Manufacturers
4.2.1 Global Sacubitril API Sales by Manufacturers (2017-2022)
4.2.2 Global Sacubitril API Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Sacubitril API in 2021
4.3 Global Sacubitril API Revenue by Manufacturers
4.3.1 Global Sacubitril API Revenue by Manufacturers (2017-2022)
4.3.2 Global Sacubitril API Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Sacubitril API Revenue in 2021
4.4 Global Sacubitril API Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Sacubitril API Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Sacubitril API Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Purity
5.1 Global Sacubitril API Sales by Purity
5.1.1 Global Sacubitril API Historical Sales by Purity (2017-2022)
5.1.2 Global Sacubitril API Forecasted Sales by Purity (2023-2028)
5.1.3 Global Sacubitril API Sales Market Share by Purity (2017-2028)
5.2 Global Sacubitril API Revenue by Purity
5.2.1 Global Sacubitril API Historical Revenue by Purity (2017-2022)
5.2.2 Global Sacubitril API Forecasted Revenue by Purity (2023-2028)
5.2.3 Global Sacubitril API Revenue Market Share by Purity (2017-2028)
5.3 Global Sacubitril API Price by Purity
5.3.1 Global Sacubitril API Price by Purity (2017-2022)
5.3.2 Global Sacubitril API Price Forecast by Purity (2023-2028)
6 Market Size by Application
6.1 Global Sacubitril API Sales by Application
6.1.1 Global Sacubitril API Historical Sales by Application (2017-2022)
6.1.2 Global Sacubitril API Forecasted Sales by Application (2023-2028)
6.1.3 Global Sacubitril API Sales Market Share by Application (2017-2028)
6.2 Global Sacubitril API Revenue by Application
6.2.1 Global Sacubitril API Historical Revenue by Application (2017-2022)
6.2.2 Global Sacubitril API Forecasted Revenue by Application (2023-2028)
6.2.3 Global Sacubitril API Revenue Market Share by Application (2017-2028)
6.3 Global Sacubitril API Price by Application
6.3.1 Global Sacubitril API Price by Application (2017-2022)
6.3.2 Global Sacubitril API Price Forecast by Application (2023-2028)
7 North America
7.1 North America Sacubitril API Market Size by Purity
7.1.1 North America Sacubitril API Sales by Purity (2017-2028)
7.1.2 North America Sacubitril API Revenue by Purity (2017-2028)
7.2 North America Sacubitril API Market Size by Application
7.2.1 North America Sacubitril API Sales by Application (2017-2028)
7.2.2 North America Sacubitril API Revenue by Application (2017-2028)
7.3 North America Sacubitril API Sales by Country
7.3.1 North America Sacubitril API Sales by Country (2017-2028)
7.3.2 North America Sacubitril API Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Sacubitril API Market Size by Purity
8.1.1 Europe Sacubitril API Sales by Purity (2017-2028)
8.1.2 Europe Sacubitril API Revenue by Purity (2017-2028)
8.2 Europe Sacubitril API Market Size by Application
8.2.1 Europe Sacubitril API Sales by Application (2017-2028)
8.2.2 Europe Sacubitril API Revenue by Application (2017-2028)
8.3 Europe Sacubitril API Sales by Country
8.3.1 Europe Sacubitril API Sales by Country (2017-2028)
8.3.2 Europe Sacubitril API Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Sacubitril API Market Size by Purity
9.1.1 Asia Pacific Sacubitril API Sales by Purity (2017-2028)
9.1.2 Asia Pacific Sacubitril API Revenue by Purity (2017-2028)
9.2 Asia Pacific Sacubitril API Market Size by Application
9.2.1 Asia Pacific Sacubitril API Sales by Application (2017-2028)
9.2.2 Asia Pacific Sacubitril API Revenue by Application (2017-2028)
9.3 Asia Pacific Sacubitril API Sales by Region
9.3.1 Asia Pacific Sacubitril API Sales by Region (2017-2028)
9.3.2 Asia Pacific Sacubitril API Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Sacubitril API Market Size by Purity
10.1.1 Latin America Sacubitril API Sales by Purity (2017-2028)
10.1.2 Latin America Sacubitril API Revenue by Purity (2017-2028)
10.2 Latin America Sacubitril API Market Size by Application
10.2.1 Latin America Sacubitril API Sales by Application (2017-2028)
10.2.2 Latin America Sacubitril API Revenue by Application (2017-2028)
10.3 Latin America Sacubitril API Sales by Country
10.3.1 Latin America Sacubitril API Sales by Country (2017-2028)
10.3.2 Latin America Sacubitril API Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sacubitril API Market Size by Purity
11.1.1 Middle East and Africa Sacubitril API Sales by Purity (2017-2028)
11.1.2 Middle East and Africa Sacubitril API Revenue by Purity (2017-2028)
11.2 Middle East and Africa Sacubitril API Market Size by Application
11.2.1 Middle East and Africa Sacubitril API Sales by Application (2017-2028)
11.2.2 Middle East and Africa Sacubitril API Revenue by Application (2017-2028)
11.3 Middle East and Africa Sacubitril API Sales by Country
11.3.1 Middle East and Africa Sacubitril API Sales by Country (2017-2028)
11.3.2 Middle East and Africa Sacubitril API Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Mylan
12.1.1 Mylan Corporation Information
12.1.2 Mylan Overview
12.1.3 Mylan Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Mylan Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Mylan Recent Developments
12.2 NEWEDGE Overseas
12.2.1 NEWEDGE Overseas Corporation Information
12.2.2 NEWEDGE Overseas Overview
12.2.3 NEWEDGE Overseas Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 NEWEDGE Overseas Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 NEWEDGE Overseas Recent Developments
12.3 Summit Pharmaceuticals Europe Srl
12.3.1 Summit Pharmaceuticals Europe Srl Corporation Information
12.3.2 Summit Pharmaceuticals Europe Srl Overview
12.3.3 Summit Pharmaceuticals Europe Srl Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Summit Pharmaceuticals Europe Srl Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Summit Pharmaceuticals Europe Srl Recent Developments
12.4 Zhejiang Tianyu Pharmaceutical
12.4.1 Zhejiang Tianyu Pharmaceutical Corporation Information
12.4.2 Zhejiang Tianyu Pharmaceutical Overview
12.4.3 Zhejiang Tianyu Pharmaceutical Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Zhejiang Tianyu Pharmaceutical Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Zhejiang Tianyu Pharmaceutical Recent Developments
12.5 Unichem Laboratories Limited
12.5.1 Unichem Laboratories Limited Corporation Information
12.5.2 Unichem Laboratories Limited Overview
12.5.3 Unichem Laboratories Limited Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Unichem Laboratories Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Unichem Laboratories Limited Recent Developments
12.6 Laurus Labs
12.6.1 Laurus Labs Corporation Information
12.6.2 Laurus Labs Overview
12.6.3 Laurus Labs Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Laurus Labs Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Laurus Labs Recent Developments
12.7 Biocon
12.7.1 Biocon Corporation Information
12.7.2 Biocon Overview
12.7.3 Biocon Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Biocon Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Biocon Recent Developments
12.8 Viwit Pharmaceuticals Limited
12.8.1 Viwit Pharmaceuticals Limited Corporation Information
12.8.2 Viwit Pharmaceuticals Limited Overview
12.8.3 Viwit Pharmaceuticals Limited Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Viwit Pharmaceuticals Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Viwit Pharmaceuticals Limited Recent Developments
12.9 Aurobindo Pharma Limited
12.9.1 Aurobindo Pharma Limited Corporation Information
12.9.2 Aurobindo Pharma Limited Overview
12.9.3 Aurobindo Pharma Limited Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Aurobindo Pharma Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Aurobindo Pharma Limited Recent Developments
12.10 Lee Pharma
12.10.1 Lee Pharma Corporation Information
12.10.2 Lee Pharma Overview
12.10.3 Lee Pharma Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Lee Pharma Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Lee Pharma Recent Developments
12.11 Bulat Pharmaceutical
12.11.1 Bulat Pharmaceutical Corporation Information
12.11.2 Bulat Pharmaceutical Overview
12.11.3 Bulat Pharmaceutical Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Bulat Pharmaceutical Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Bulat Pharmaceutical Recent Developments
12.12 Chunghwa Chemical Synthesis & Biotech Co. Ltd.
12.12.1 Chunghwa Chemical Synthesis & Biotech Co. Ltd. Corporation Information
12.12.2 Chunghwa Chemical Synthesis & Biotech Co. Ltd. Overview
12.12.3 Chunghwa Chemical Synthesis & Biotech Co. Ltd. Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Chunghwa Chemical Synthesis & Biotech Co. Ltd. Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Chunghwa Chemical Synthesis & Biotech Co. Ltd. Recent Developments
12.13 IOL Chemicals And Pharmaceuticals Limited
12.13.1 IOL Chemicals And Pharmaceuticals Limited Corporation Information
12.13.2 IOL Chemicals And Pharmaceuticals Limited Overview
12.13.3 IOL Chemicals And Pharmaceuticals Limited Sacubitril API Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 IOL Chemicals And Pharmaceuticals Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 IOL Chemicals And Pharmaceuticals Limited Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Sacubitril API Industry Chain Analysis
13.2 Sacubitril API Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Sacubitril API Production Mode & Process
13.4 Sacubitril API Sales and Marketing
13.4.1 Sacubitril API Sales Channels
13.4.2 Sacubitril API Distributors
13.5 Sacubitril API Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Sacubitril API Industry Trends
14.2 Sacubitril API Market Drivers
14.3 Sacubitril API Market Challenges
14.4 Sacubitril API Market Restraints
15 Key Finding in The Global Sacubitril API Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Global Sacubitril API Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Above 98 %
Table 3. Major Manufacturers of Above 99 %
Table 4. Global Sacubitril API Market Size Growth Rate by Application, 2017 VS 2021 2028 (US$ Million)
Table 5. Global Sacubitril API Production by Region: 2017 VS 2021 VS 2028 (Kg)
Table 6. Global Sacubitril API Production by Region (2017-2022) & (Kg)
Table 7. Global Sacubitril API Production Market Share by Region (2017-2022)
Table 8. Global Sacubitril API Production by Region (2023-2028) & (Kg)
Table 9. Global Sacubitril API Production Market Share by Region (2023-2028)
Table 10. Global Sacubitril API Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 11. Global Sacubitril API Sales by Region (2017-2022) & (Kg)
Table 12. Global Sacubitril API Sales Market Share by Region (2017-2022)
Table 13. Global Sacubitril API Sales by Region (2023-2028) & (Kg)
Table 14. Global Sacubitril API Sales Market Share by Region (2023-2028)
Table 15. Global Sacubitril API Revenue by Region (2017-2022) & (US$ Million)
Table 16. Global Sacubitril API Revenue Market Share by Region (2017-2022)
Table 17. Global Sacubitril API Revenue by Region (2023-2028) & (US$ Million)
Table 18. Global Sacubitril API Revenue Market Share by Region (2023-2028)
Table 19. Global Sacubitril API Production Capacity by Manufacturers (2017-2022) & (Kg)
Table 20. Global Sacubitril API Capacity Market Share by Manufacturers (2017-2022)
Table 21. Global Sacubitril API Sales by Manufacturers (2017-2022) & (Kg)
Table 22. Global Sacubitril API Sales Market Share by Manufacturers (2017-2022)
Table 23. Global Sacubitril API Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 24. Global Sacubitril API Revenue Share by Manufacturers (2017-2022)
Table 25. Sacubitril API Price by Manufacturers 2017-2022 (US$/Kg)
Table 26. Global Sacubitril API Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 27. Global Sacubitril API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sacubitril API as of 2021)
Table 28. Sacubitril API Manufacturing Base Distribution and Headquarters
Table 29. Manufacturers Sacubitril API Product Offered
Table 30. Date of Manufacturers Enter into Sacubitril API Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Sacubitril API Sales by Purity (2017-2022) & (Kg)
Table 33. Global Sacubitril API Sales by Purity (2023-2028) & (Kg)
Table 34. Global Sacubitril API Sales Share by Purity (2017-2022)
Table 35. Global Sacubitril API Sales Share by Purity (2023-2028)
Table 36. Global Sacubitril API Revenue by Purity (2017-2022) & (US$ Million)
Table 37. Global Sacubitril API Revenue by Purity (2023-2028) & (US$ Million)
Table 38. Global Sacubitril API Revenue Share by Purity (2017-2022)
Table 39. Global Sacubitril API Revenue Share by Purity (2023-2028)
Table 40. Sacubitril API Price by Purity (2017-2022) & (US$/Kg)
Table 41. Global Sacubitril API Price Forecast by Purity (2023-2028) & (US$/Kg)
Table 42. Global Sacubitril API Sales by Application (2017-2022) & (Kg)
Table 43. Global Sacubitril API Sales by Application (2023-2028) & (Kg)
Table 44. Global Sacubitril API Sales Share by Application (2017-2022)
Table 45. Global Sacubitril API Sales Share by Application (2023-2028)
Table 46. Global Sacubitril API Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Sacubitril API Revenue by Application (2023-2028) & (US$ Million)
Table 48. Global Sacubitril API Revenue Share by Application (2017-2022)
Table 49. Global Sacubitril API Revenue Share by Application (2023-2028)
Table 50. Sacubitril API Price by Application (2017-2022) & (US$/Kg)
Table 51. Global Sacubitril API Price Forecast by Application (2023-2028) & (US$/Kg)
Table 52. North America Sacubitril API Sales by Purity (2017-2022) & (Kg)
Table 53. North America Sacubitril API Sales by Purity (2023-2028) & (Kg)
Table 54. North America Sacubitril API Revenue by Purity (2017-2022) & (US$ Million)
Table 55. North America Sacubitril API Revenue by Purity (2023-2028) & (US$ Million)
Table 56. North America Sacubitril API Sales by Application (2017-2022) & (Kg)
Table 57. North America Sacubitril API Sales by Application (2023-2028) & (Kg)
Table 58. North America Sacubitril API Revenue by Application (2017-2022) & (US$ Million)
Table 59. North America Sacubitril API Revenue by Application (2023-2028) & (US$ Million)
Table 60. North America Sacubitril API Sales by Country (2017-2022) & (Kg)
Table 61. North America Sacubitril API Sales by Country (2023-2028) & (Kg)
Table 62. North America Sacubitril API Revenue by Country (2017-2022) & (US$ Million)
Table 63. North America Sacubitril API Revenue by Country (2023-2028) & (US$ Million)
Table 64. Europe Sacubitril API Sales by Purity (2017-2022) & (Kg)
Table 65. Europe Sacubitril API Sales by Purity (2023-2028) & (Kg)
Table 66. Europe Sacubitril API Revenue by Purity (2017-2022) & (US$ Million)
Table 67. Europe Sacubitril API Revenue by Purity (2023-2028) & (US$ Million)
Table 68. Europe Sacubitril API Sales by Application (2017-2022) & (Kg)
Table 69. Europe Sacubitril API Sales by Application (2023-2028) & (Kg)
Table 70. Europe Sacubitril API Revenue by Application (2017-2022) & (US$ Million)
Table 71. Europe Sacubitril API Revenue by Application (2023-2028) & (US$ Million)
Table 72. Europe Sacubitril API Sales by Country (2017-2022) & (Kg)
Table 73. Europe Sacubitril API Sales by Country (2023-2028) & (Kg)
Table 74. Europe Sacubitril API Revenue by Country (2017-2022) & (US$ Million)
Table 75. Europe Sacubitril API Revenue by Country (2023-2028) & (US$ Million)
Table 76. Asia Pacific Sacubitril API Sales by Purity (2017-2022) & (Kg)
Table 77. Asia Pacific Sacubitril API Sales by Purity (2023-2028) & (Kg)
Table 78. Asia Pacific Sacubitril API Revenue by Purity (2017-2022) & (US$ Million)
Table 79. Asia Pacific Sacubitril API Revenue by Purity (2023-2028) & (US$ Million)
Table 80. Asia Pacific Sacubitril API Sales by Application (2017-2022) & (Kg)
Table 81. Asia Pacific Sacubitril API Sales by Application (2023-2028) & (Kg)
Table 82. Asia Pacific Sacubitril API Revenue by Application (2017-2022) & (US$ Million)
Table 83. Asia Pacific Sacubitril API Revenue by Application (2023-2028) & (US$ Million)
Table 84. Asia Pacific Sacubitril API Sales by Region (2017-2022) & (Kg)
Table 85. Asia Pacific Sacubitril API Sales by Region (2023-2028) & (Kg)
Table 86. Asia Pacific Sacubitril API Revenue by Region (2017-2022) & (US$ Million)
Table 87. Asia Pacific Sacubitril API Revenue by Region (2023-2028) & (US$ Million)
Table 88. Latin America Sacubitril API Sales by Purity (2017-2022) & (Kg)
Table 89. Latin America Sacubitril API Sales by Purity (2023-2028) & (Kg)
Table 90. Latin America Sacubitril API Revenue by Purity (2017-2022) & (US$ Million)
Table 91. Latin America Sacubitril API Revenue by Purity (2023-2028) & (US$ Million)
Table 92. Latin America Sacubitril API Sales by Application (2017-2022) & (Kg)
Table 93. Latin America Sacubitril API Sales by Application (2023-2028) & (Kg)
Table 94. Latin America Sacubitril API Revenue by Application (2017-2022) & (US$ Million)
Table 95. Latin America Sacubitril API Revenue by Application (2023-2028) & (US$ Million)
Table 96. Latin America Sacubitril API Sales by Country (2017-2022) & (Kg)
Table 97. Latin America Sacubitril API Sales by Country (2023-2028) & (Kg)
Table 98. Latin America Sacubitril API Revenue by Country (2017-2022) & (US$ Million)
Table 99. Latin America Sacubitril API Revenue by Country (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Sacubitril API Sales by Purity (2017-2022) & (Kg)
Table 101. Middle East and Africa Sacubitril API Sales by Purity (2023-2028) & (Kg)
Table 102. Middle East and Africa Sacubitril API Revenue by Purity (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Sacubitril API Revenue by Purity (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Sacubitril API Sales by Application (2017-2022) & (Kg)
Table 105. Middle East and Africa Sacubitril API Sales by Application (2023-2028) & (Kg)
Table 106. Middle East and Africa Sacubitril API Revenue by Application (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Sacubitril API Revenue by Application (2023-2028) & (US$ Million)
Table 108. Middle East and Africa Sacubitril API Sales by Country (2017-2022) & (Kg)
Table 109. Middle East and Africa Sacubitril API Sales by Country (2023-2028) & (Kg)
Table 110. Middle East and Africa Sacubitril API Revenue by Country (2017-2022) & (US$ Million)
Table 111. Middle East and Africa Sacubitril API Revenue by Country (2023-2028) & (US$ Million)
Table 112. Mylan Corporation Information
Table 113. Mylan Description and Major Businesses
Table 114. Mylan Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 115. Mylan Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Mylan Recent Development
Table 117. NEWEDGE Overseas Corporation Information
Table 118. NEWEDGE Overseas Description and Major Businesses
Table 119. NEWEDGE Overseas Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 120. NEWEDGE Overseas Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. NEWEDGE Overseas Recent Development
Table 122. Summit Pharmaceuticals Europe Srl Corporation Information
Table 123. Summit Pharmaceuticals Europe Srl Description and Major Businesses
Table 124. Summit Pharmaceuticals Europe Srl Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 125. Summit Pharmaceuticals Europe Srl Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Summit Pharmaceuticals Europe Srl Recent Development
Table 127. Zhejiang Tianyu Pharmaceutical Corporation Information
Table 128. Zhejiang Tianyu Pharmaceutical Description and Major Businesses
Table 129. Zhejiang Tianyu Pharmaceutical Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 130. Zhejiang Tianyu Pharmaceutical Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Zhejiang Tianyu Pharmaceutical Recent Development
Table 132. Unichem Laboratories Limited Corporation Information
Table 133. Unichem Laboratories Limited Description and Major Businesses
Table 134. Unichem Laboratories Limited Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 135. Unichem Laboratories Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Unichem Laboratories Limited Recent Development
Table 137. Laurus Labs Corporation Information
Table 138. Laurus Labs Description and Major Businesses
Table 139. Laurus Labs Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 140. Laurus Labs Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Laurus Labs Recent Development
Table 142. Biocon Corporation Information
Table 143. Biocon Description and Major Businesses
Table 144. Biocon Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 145. Biocon Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biocon Recent Development
Table 147. Viwit Pharmaceuticals Limited Corporation Information
Table 148. Viwit Pharmaceuticals Limited Description and Major Businesses
Table 149. Viwit Pharmaceuticals Limited Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 150. Viwit Pharmaceuticals Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Viwit Pharmaceuticals Limited Recent Development
Table 152. Aurobindo Pharma Limited Corporation Information
Table 153. Aurobindo Pharma Limited Description and Major Businesses
Table 154. Aurobindo Pharma Limited Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 155. Aurobindo Pharma Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Aurobindo Pharma Limited Recent Development
Table 157. Lee Pharma Corporation Information
Table 158. Lee Pharma Description and Major Businesses
Table 159. Lee Pharma Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 160. Lee Pharma Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Lee Pharma Recent Development
Table 162. Bulat Pharmaceutical Corporation Information
Table 163. Bulat Pharmaceutical Description and Major Businesses
Table 164. Bulat Pharmaceutical Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 165. Bulat Pharmaceutical Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Bulat Pharmaceutical Recent Development
Table 167. Chunghwa Chemical Synthesis & Biotech Co. Ltd. Corporation Information
Table 168. Chunghwa Chemical Synthesis & Biotech Co. Ltd. Description and Major Businesses
Table 169. Chunghwa Chemical Synthesis & Biotech Co. Ltd. Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 170. Chunghwa Chemical Synthesis & Biotech Co. Ltd. Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Chunghwa Chemical Synthesis & Biotech Co. Ltd. Recent Development
Table 172. IOL Chemicals And Pharmaceuticals Limited Corporation Information
Table 173. IOL Chemicals And Pharmaceuticals Limited Description and Major Businesses
Table 174. IOL Chemicals And Pharmaceuticals Limited Sacubitril API Sales (Kg), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2017-2022)
Table 175. IOL Chemicals And Pharmaceuticals Limited Sacubitril API Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. IOL Chemicals And Pharmaceuticals Limited Recent Development
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Sacubitril API Distributors List
Table 180. Sacubitril API Customers List
Table 181. Sacubitril API Market Trends
Table 182. Sacubitril API Market Drivers
Table 183. Sacubitril API Market Challenges
Table 184. Sacubitril API Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Sacubitril API Product Picture
Figure 2. Global Sacubitril API Market Share by Purity in 2021 & 2028
Figure 3. Above 98 % Product Picture
Figure 4. Above 99 % Product Picture
Figure 5. Global Sacubitril API Market Share by Application in 2021 & 2028
Figure 6. Tablets
Figure 7. Others
Figure 8. Sacubitril API Report Years Considered
Figure 9. Global Sacubitril API Capacity, Production and Utilization (2017-2028) & (Kg)
Figure 10. Global Sacubitril API Production Market Share by Region in Percentage: 2021 Versus 2028
Figure 11. Global Sacubitril API Production Market Share by Region (2017-2022)
Figure 12. Global Sacubitril API Production Market Share by Region (2023-2028)
Figure 13. Sacubitril API Production Growth Rate in North America (2017-2028) & (Kg)
Figure 14. Sacubitril API Production Growth Rate in Europe (2017-2028) & (Kg)
Figure 15. Sacubitril API Production Growth Rate in China (2017-2028) & (Kg)
Figure 16. Sacubitril API Production Growth Rate in India (2017-2028) & (Kg)
Figure 17. Global Sacubitril API Sales 2017-2028 (Kg)
Figure 18. Global Sacubitril API Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 19. Global Sacubitril API Revenue 2017-2028 (US$ Million)
Figure 20. Global Sacubitril API Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 21. Global Sacubitril API Sales Market Share by Region (2017-2022)
Figure 22. Global Sacubitril API Sales Market Share by Region (2023-2028)
Figure 23. North America Sacubitril API Sales YoY (2017-2028) & (Kg)
Figure 24. North America Sacubitril API Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Europe Sacubitril API Sales YoY (2017-2028) & (Kg)
Figure 26. Europe Sacubitril API Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Asia-Pacific Sacubitril API Sales YoY (2017-2028) & (Kg)
Figure 28. Asia-Pacific Sacubitril API Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Latin America Sacubitril API Sales YoY (2017-2028) & (Kg)
Figure 30. Latin America Sacubitril API Revenue YoY (2017-2028) & (US$ Million)
Figure 31. Middle East & Africa Sacubitril API Sales YoY (2017-2028) & (Kg)
Figure 32. Middle East & Africa Sacubitril API Revenue YoY (2017-2028) & (US$ Million)
Figure 33. The Sacubitril API Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 34. The Top 5 and 10 Largest Manufacturers of Sacubitril API in the World: Market Share by Sacubitril API Revenue in 2021
Figure 35. Sacubitril API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 36. Global Sacubitril API Sales Market Share by Purity (2017-2028)
Figure 37. Global Sacubitril API Revenue Market Share by Purity (2017-2028)
Figure 38. Global Sacubitril API Sales Market Share by Application (2017-2028)
Figure 39. Global Sacubitril API Revenue Market Share by Application (2017-2028)
Figure 40. North America Sacubitril API Sales Market Share by Purity (2017-2028)
Figure 41. North America Sacubitril API Revenue Market Share by Purity (2017-2028)
Figure 42. North America Sacubitril API Sales Market Share by Application (2017-2028)
Figure 43. North America Sacubitril API Revenue Market Share by Application (2017-2028)
Figure 44. North America Sacubitril API Sales Share by Country (2017-2028)
Figure 45. North America Sacubitril API Revenue Share by Country (2017-2028)
Figure 46. United States Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 47. Canada Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 48. Europe Sacubitril API Sales Market Share by Purity (2017-2028)
Figure 49. Europe Sacubitril API Revenue Market Share by Purity (2017-2028)
Figure 50. Europe Sacubitril API Sales Market Share by Application (2017-2028)
Figure 51. Europe Sacubitril API Revenue Market Share by Application (2017-2028)
Figure 52. Europe Sacubitril API Sales Share by Country (2017-2028)
Figure 53. Europe Sacubitril API Revenue Share by Country (2017-2028)
Figure 54. Germany Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 55. France Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 56. U.K. Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 57. Italy Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 58. Russia Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 59. Asia Pacific Sacubitril API Sales Market Share by Purity (2017-2028)
Figure 60. Asia Pacific Sacubitril API Revenue Market Share by Purity (2017-2028)
Figure 61. Asia Pacific Sacubitril API Sales Market Share by Application (2017-2028)
Figure 62. Asia Pacific Sacubitril API Revenue Market Share by Application (2017-2028)
Figure 63. Asia Pacific Sacubitril API Sales Share by Region (2017-2028)
Figure 64. Asia Pacific Sacubitril API Revenue Share by Region (2017-2028)
Figure 65. China Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 66. Japan Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 67. South Korea Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 68. India Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 69. Australia Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 70. China Taiwan Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 71. Indonesia Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 72. Thailand Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 73. Malaysia Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 74. Latin America Sacubitril API Sales Market Share by Purity (2017-2028)
Figure 75. Latin America Sacubitril API Revenue Market Share by Purity (2017-2028)
Figure 76. Latin America Sacubitril API Sales Market Share by Application (2017-2028)
Figure 77. Latin America Sacubitril API Revenue Market Share by Application (2017-2028)
Figure 78. Latin America Sacubitril API Sales Share by Country (2017-2028)
Figure 79. Latin America Sacubitril API Revenue Share by Country (2017-2028)
Figure 80. Mexico Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 81. Brazil Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 82. Argentina Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 83. Middle East and Africa Sacubitril API Sales Market Share by Purity (2017-2028)
Figure 84. Middle East and Africa Sacubitril API Revenue Market Share by Purity (2017-2028)
Figure 85. Middle East and Africa Sacubitril API Sales Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Sacubitril API Revenue Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Sacubitril API Sales Share by Country (2017-2028)
Figure 88. Middle East and Africa Sacubitril API Revenue Share by Country (2017-2028)
Figure 89. Turkey Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 90. Saudi Arabia Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 91. UAE Sacubitril API Revenue (2017-2028) & (US$ Million)
Figure 92. Sacubitril API Value Chain
Figure 93. Sacubitril API Production Process
Figure 94. Channels of Distribution
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed